| Dr Chukwusomnazu Emmanuel Nwanze, MD | |
|
1 Medical Center Dr, Lebanon, NH 03756-1000 | |
| (706) 571-1430 | |
| Not Available |
| Full Name | Dr Chukwusomnazu Emmanuel Nwanze |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 17 Years |
| Location | 1 Medical Center Dr, Lebanon, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043506066 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Laredo Medical Center | Laredo, TX | Hospital |
| Las Palmas Medical Center | El paso, TX | Hospital |
| The Hospitals Of Providence - Memorial Campus | El paso, TX | Hospital |
| The Hospitals Of Providence - Sierra Campus | El paso, TX | Hospital |
| The Hospitals Of Providence Transmountain Campus | El paso, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Singleton Associates Pa | 6305731118 | 691 |
News Archive
Boehringer Ingelheim and Eli Lilly and Company announce new data that reinforce the efficacy and tolerability of linagliptin in people with Type 2 Diabetes and liver disease, as well as Asian people with T2D aged 65 years or older.
Every year, more than 11 million children die, six million of them from preventable diseases, like malaria, measles and diarrhoea. The UN Millennium Project, in its report to be released next week, outlines a plan to stop those children's deaths, cut poverty in half and change the lives of billions of poor people the world over by the year 2015.
SARS-CoV-2, the virus that causes COVID-19, continues to spread, leading to more than 20,000 deaths worldwide in less than four months. Efforts are progressing to develop a COVID-19 vaccine, but it's still likely 12 to 18 months away.
UT Southwestern researchers have identified two proteins that act as gatekeepers to dampen a potentially life-threatening immune response to chronic infection.
Roche Applied Science announces the availability of the new CIM-Plate 16 for their xCELLigence System for cell analysis, for use in cancer research. The 16-well culture plate features electronic sensors for the direct study of cell migration and invasion on the xCELLigence RTCA DP Instrument.
› Verified 7 days ago
| Entity Name | Singleton Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538107875 PECOS PAC ID: 6305731118 Enrollment ID: O20040315000385 |
News Archive
Boehringer Ingelheim and Eli Lilly and Company announce new data that reinforce the efficacy and tolerability of linagliptin in people with Type 2 Diabetes and liver disease, as well as Asian people with T2D aged 65 years or older.
Every year, more than 11 million children die, six million of them from preventable diseases, like malaria, measles and diarrhoea. The UN Millennium Project, in its report to be released next week, outlines a plan to stop those children's deaths, cut poverty in half and change the lives of billions of poor people the world over by the year 2015.
SARS-CoV-2, the virus that causes COVID-19, continues to spread, leading to more than 20,000 deaths worldwide in less than four months. Efforts are progressing to develop a COVID-19 vaccine, but it's still likely 12 to 18 months away.
UT Southwestern researchers have identified two proteins that act as gatekeepers to dampen a potentially life-threatening immune response to chronic infection.
Roche Applied Science announces the availability of the new CIM-Plate 16 for their xCELLigence System for cell analysis, for use in cancer research. The 16-well culture plate features electronic sensors for the direct study of cell migration and invasion on the xCELLigence RTCA DP Instrument.
› Verified 7 days ago
| Entity Name | Regional Employee Assistance Program Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649232984 PECOS PAC ID: 1557260064 Enrollment ID: O20040612000731 |
News Archive
Boehringer Ingelheim and Eli Lilly and Company announce new data that reinforce the efficacy and tolerability of linagliptin in people with Type 2 Diabetes and liver disease, as well as Asian people with T2D aged 65 years or older.
Every year, more than 11 million children die, six million of them from preventable diseases, like malaria, measles and diarrhoea. The UN Millennium Project, in its report to be released next week, outlines a plan to stop those children's deaths, cut poverty in half and change the lives of billions of poor people the world over by the year 2015.
SARS-CoV-2, the virus that causes COVID-19, continues to spread, leading to more than 20,000 deaths worldwide in less than four months. Efforts are progressing to develop a COVID-19 vaccine, but it's still likely 12 to 18 months away.
UT Southwestern researchers have identified two proteins that act as gatekeepers to dampen a potentially life-threatening immune response to chronic infection.
Roche Applied Science announces the availability of the new CIM-Plate 16 for their xCELLigence System for cell analysis, for use in cancer research. The 16-well culture plate features electronic sensors for the direct study of cell migration and invasion on the xCELLigence RTCA DP Instrument.
› Verified 7 days ago
| Entity Name | Sierra Vista Hospital 69 |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760446009 PECOS PAC ID: 0143122416 Enrollment ID: O20170718001318 |
News Archive
Boehringer Ingelheim and Eli Lilly and Company announce new data that reinforce the efficacy and tolerability of linagliptin in people with Type 2 Diabetes and liver disease, as well as Asian people with T2D aged 65 years or older.
Every year, more than 11 million children die, six million of them from preventable diseases, like malaria, measles and diarrhoea. The UN Millennium Project, in its report to be released next week, outlines a plan to stop those children's deaths, cut poverty in half and change the lives of billions of poor people the world over by the year 2015.
SARS-CoV-2, the virus that causes COVID-19, continues to spread, leading to more than 20,000 deaths worldwide in less than four months. Efforts are progressing to develop a COVID-19 vaccine, but it's still likely 12 to 18 months away.
UT Southwestern researchers have identified two proteins that act as gatekeepers to dampen a potentially life-threatening immune response to chronic infection.
Roche Applied Science announces the availability of the new CIM-Plate 16 for their xCELLigence System for cell analysis, for use in cancer research. The 16-well culture plate features electronic sensors for the direct study of cell migration and invasion on the xCELLigence RTCA DP Instrument.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Chukwusomnazu Emmanuel Nwanze, MD 1 Medical Center Dr, Lebanon, NH 03756-1000 Ph: () - | Dr Chukwusomnazu Emmanuel Nwanze, MD 1 Medical Center Dr, Lebanon, NH 03756-1000 Ph: (706) 571-1430 |
News Archive
Boehringer Ingelheim and Eli Lilly and Company announce new data that reinforce the efficacy and tolerability of linagliptin in people with Type 2 Diabetes and liver disease, as well as Asian people with T2D aged 65 years or older.
Every year, more than 11 million children die, six million of them from preventable diseases, like malaria, measles and diarrhoea. The UN Millennium Project, in its report to be released next week, outlines a plan to stop those children's deaths, cut poverty in half and change the lives of billions of poor people the world over by the year 2015.
SARS-CoV-2, the virus that causes COVID-19, continues to spread, leading to more than 20,000 deaths worldwide in less than four months. Efforts are progressing to develop a COVID-19 vaccine, but it's still likely 12 to 18 months away.
UT Southwestern researchers have identified two proteins that act as gatekeepers to dampen a potentially life-threatening immune response to chronic infection.
Roche Applied Science announces the availability of the new CIM-Plate 16 for their xCELLigence System for cell analysis, for use in cancer research. The 16-well culture plate features electronic sensors for the direct study of cell migration and invasion on the xCELLigence RTCA DP Instrument.
› Verified 7 days ago
Thomas Ray Burdick, Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5000 | |
William B. Zucconi, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5000 | |
Dr. Thomas Francis Delaney, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-6600 | |
Dr. Jessica Margaret Sin, M.D., PH.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Dr, Lebanon, NH 03756 Phone: 603-650-7650 | |
Dr. Harlan G Herr, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-7650 | |
Matthew E Maeder, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-4371 | |
Dr. Judith Austin-strohbehn, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Department Of Radiology, Lebanon, NH 03756 Phone: 603-650-4477 Fax: 603-650-5455 |